(Q37737548)

22 August 2017

1 reference

title

Management of prostate cancer in HIV-positive patients (English)

1 reference

22 August 2017

1 reference

2

Franklin C Lowe

1 reference

22 August 2017

Matthew S Wosnitzer

1

1 reference

22 August 2017

language of work or name

English

0 references

publication date

27 April 2010

1 reference

22 August 2017

published in

Nature Reviews Urology

1 reference

22 August 2017

volume

7

1 reference

22 August 2017

issue

6

1 reference

22 August 2017

page(s)

348-357

1 reference

Cancer risk in the Swiss HIV Cohort Study: associations with immunodeficiency, smoking, and highly active antiretroviral therapy

22 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2010.61

Proliferative inflammatory atrophy of the prostate: implications for prostatic carcinogenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2010.61

Enhancement of anti-melanoma activity of a plasmid expressing HIV-1 Vpr delivered through in vivo electroporation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2010.61

Anti-tumor activity mediated by protein and peptide transduction of HIV viral protein R (Vpr).

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2010.61

Lower endogenous androgen levels and dyslipidemia in men with non-insulin-dependent diabetes mellitus

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2010.61

Sexual dysfunction in HIV-infected patients treated with highly active antiretroviral therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2010.61

Outcomes of chemoradiotherapy with 5-Fluorouracil and mitomycin C for anal cancer in immunocompetent versus immunodeficient patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2010.61

Serum albumin is a powerful predictor of survival among HIV-1-infected women

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2010.61

Combined Genome-Wide Scan for Prostate Cancer Susceptibility Genes

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2010.61

21 January 2018

Cancer statistics, 2009

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2010.61

Characteristics of prostate cancers detected in a multimodality early detection program. The Investigators of the American Cancer Society-National Prostate Cancer Detection Project

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2010.61

Temporal trends in rates of prostate cancer: declining incidence of advanced stage disease, 1974 to 1994.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2010.61

Genitourinary manifestations of the acquired immunodeficiency syndrome

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2010.61

Androgen therapy in AIDS wasting

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2010.61

Increased risk of prostate cancer in HIV infection?

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2010.61

Risk of cancer in persons with AIDS in Italy, 1985-1998.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2010.61

Trends in cancer risk among people with AIDS in the United States 1980-2002.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2010.61

Improved survival in HIV-related Hodgkin's lymphoma since the introduction of highly active antiretroviral therapy

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2010.61

The impact of highly active antiretroviral therapy on non-AIDS-defining cancers among adults with AIDS.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2010.61

Human immunodeficiency virus-associated prostate cancer: clinicopathological findings and outcome in a multi-institutional study

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2010.61

Incidence of types of cancer among HIV-infected persons compared with the general population in the United States, 1992-2003

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2010.61

Should HIV patients be considered a high risk group for the development of prostate cancer?

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2010.61

A population-based analysis of temporal trends in the incidence of squamous anal canal cancer in relation to the HIV epidemic

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2010.61

31 March 2020

2 references

https://api.crossref.org/works/10.1038%2FNRUROL.2010.61

31 March 2020

12 December 2020

Risk of breast, ovary, and uterine corpus cancers among 85,268 women with AIDS.

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2010.61

Cancer risk among participants in the women's interagency HIV study

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2010.61

Cancer risk in elderly persons with HIV/AIDS.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2010.61

Association of Cancer With AIDS-Related Immunosuppression in Adults

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2010.61

HIV infection and the risk of cancers with and without a known infectious cause

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2010.61

Continuing declines in some but not all HIV-associated cancers in Australia after widespread use of antiretroviral therapy

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2010.61

31 March 2020

Inflammation and cancer

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2010.61

Cancer incidence in New York State acquired immunodeficiency syndrome patients

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2010.61

The risk of cancer in HIV-infected people in southeast England: a cohort study

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2010.61

Risk of germ cell tumors among men with HIV/acquired immunodeficiency syndrome

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2010.61

Trends in the incidence of cancers among HIV-infected persons and the impact of antiretroviral therapy: a 20-year cohort study

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2010.61

HIV and prostate cancer: a systematic review of the literature

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2010.61

Incidence of non-AIDS-defining malignancies in HIV-infected versus noninfected patients in the HAART era: impact of immunosuppression

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2010.61

Association between HIV status and positive prostate biopsy in a study of US veterans.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2010.61

Prostate cancer in HIV infection

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2010.61

Prostate carcinoma among men with human immunodeficiency virus infection

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2010.61

Incidence and risk factors for the occurrence of non-AIDS-defining cancers among human immunodeficiency virus-infected individuals

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2010.61

Incidence of de-novo breast cancer in women chronically immunosuppressed after organ transplantation

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2010.61

Mortality among participants in the Multicenter AIDS Cohort Study and the Women's Interagency HIV Study.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2010.61

Evaluation of lymphocyte immunity in breast cancer patients

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2010.61

Mechanism of HIV spread from lymphocytes to epithelia

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2010.61

Productive HIV-1 infection of normal human mammary epithelial cells

31 March 2020

2 references

https://api.crossref.org/works/10.1038%2FNRUROL.2010.61

31 March 2020

12 December 2020

Effects of HIV protease inhibitor ritonavir on Akt-regulated cell proliferation in breast cancer

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2010.61

The impact of nelfinavir exposure on cancer development among a large cohort of HIV-infected patients

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2010.61

HIV-1 protease inhibitor induces growth arrest and apoptosis of human prostate cancer LNCaP cells in vitro and in vivo in conjunction with blockade of androgen receptor STAT3 and AKT signaling

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2010.61

Incidence of cancers in people with HIV/AIDS compared with immunosuppressed transplant recipients: a meta-analysis

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2010.61

Cumulative association of five genetic variants with prostate cancer

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2010.61

Inflammation, infection, and prostate cancer

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2010.61

An investigation of the familial aspects of carcinoma of the prostate

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2010.61

Human prostate cancer risk factors

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2010.61

Obesity and biochemical outcome following radical prostatectomy for organ confined disease with negative surgical margins

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2010.61

The effect of protease inhibitors on weight and body composition in HIV-infected patients

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2010.61

Overweight, Obesity, and Mortality from Cancer in a Prospectively Studied Cohort of U.S. Adults

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2010.61

Prediagnostic body-mass index, plasma C-peptide concentration, and prostate cancer-specific mortality in men with prostate cancer: a long-term survival analysis

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2010.61

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2010.61

Unusual malignant tumours in patients with HIV infection

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2010.61

Approach to management of clinically localized prostate cancer in patients with human immunodeficiency virus

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2010.61

Endocrine disorders in men infected with human immunodeficiency virus

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2010.61

Endocrine function in 98 HIV-infected patients: a prospective study

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2010.61

Prevalence of hypogonadism among men with weight loss related to human immunodeficiency virus infection who were receiving highly active antiretroviral therapy

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2010.61

A review of hypogonadism and erectile dysfunction among HIV-infected men during the pre- and post-HAART eras: diagnosis, pathogenesis, and management

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2010.61

Sero-epidemiological association between human-papillomavirus infection and risk of prostate cancer

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2010.61

Human papillomavirus 16, 18, and 33 infections and risk of prostate cancer: a Nordic nested case-control study

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2010.61

Case number and the financial impact of circumcision in reducing prostate cancer

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2010.61

Circumcision and/or vaccination against human papillomavirus in the male to prevent infection with human immunodeficiency virus: an early surrogate endpoint for the later prevention of penile, prostate, anal and oral cancer?

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2010.61

RETRACTED: XMRV is present in malignant prostatic epithelium and is associated with prostate cancer, especially high-grade tumors

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2010.61

Xenotropic murine leukemia virus-related virus is susceptible to AZT.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2010.61

CXCR4-gp120-IIIB interactions induce caspase-mediated apoptosis of prostate cancer cells and inhibit tumor growth

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2010.61

Androgen and gonadotropin patterns differ in HIV-1-infected men who develop lipoatrophy during antiretroviral therapy: a case-control study

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2010.61

Increasing insulin resistance is associated with a decrease in Leydig cell testosterone secretion in men.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2010.61

A close association between insulin resistance and dehydroepiandrosterone sulfate in subjects with essential hypertension.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2010.61

Mortality results from a randomized prostate-cancer screening trial

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2010.61

Screening and prostate-cancer mortality in a randomized European study

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2010.61

Screening HIV-infected patients for non-AIDS-defining malignancies

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2010.61

Prostate specific antigen best practice statement: 2009 update.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2010.61

The Lifetime Cost of Current Human Immunodeficiency Virus Care in the United States

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2010.61

Chemoprevention of prostate cancer in men at high risk: rationale and design of the reduction by dutasteride of prostate cancer events (REDUCE) trial

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2010.61

The influence of finasteride on the development of prostate cancer

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2010.61

Disseminated, lethal prostate cancer during human immunodeficiency virus infection presenting with non-specific features. Open questions for urologists, oncologists, and infectious disease specialists.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2010.61

The prostate as a reservoir for HIV-1.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2010.61

Interaction between HIV-1 Tat and pRb2/p130: a possible mechanism in the pathogenesis of AIDS-related neoplasms.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2010.61

Germ cell tumors in patients infected by the human immunodeficiency virus

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2010.61

Therapeutic management of de novo urological malignancy in renal transplant recipients: the experience of the French Department of Urology and Kidney Transplantation from Bordeaux

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2010.61

Prostate adenocarcinoma and human immunodeficiency virus: report of three cases and review of the literature

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2010.61

The significance of pretreatment CD4 count on the outcome and treatment tolerance of HIV-positive patients with anal cancer

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2010.61

Preliminary results of radiation therapy for prostate cancer in human immunodeficiency virus-positive patients

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2010.61

Radical prostatectomy in patients infected with human immunodeficiency virus

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2010.61

An analysis of men with clinically localized prostate cancer who deferred definitive therapy

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2010.61

CD4 cell counts as a prognostic factor of major abdominal surgery in patients infected with the human immunodeficiency virus

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2010.61

Abdominal aortic surgery in patients with human immunodeficiency virus infection

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2010.61

Rates of postoperative complications among human immunodeficiency virus-infected women who have undergone obstetric and gynecologic surgical procedures

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2010.61

HIV-positive patients with anal carcinoma have poorer treatment tolerance and outcome than HIV-negative patients

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2010.61

The efficacy of chemoradiation therapy in HIV seropositive patients with squamous cell carcinoma of the anus

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2010.61

Association of serum albumin and mortality risk

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2010.61

Association between serum albumin and mortality from cardiovascular disease, cancer, and other causes

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2010.61

The role of pretreatment serum albumin to predict pathological stage and recurrence among radical prostatectomy cases

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2010.61

HIV-1 protease inhibitor, ritonavir: a potent inhibitor of CYP3A4, enhanced the anticancer effects of docetaxel in androgen-independent prostate cancer cells in vitro and in vivo

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2010.61

Hereditary prostate cancer: clinical characteristics and survival

31 March 2020

1 reference

12 December 2020

Serum androgens and sex hormone-binding globulins in relation to lifestyle factors in older African-American, white, and Asian men in the United States and Canada.

1 reference

12 December 2020

Expectant management of nonpalpable prostate cancer with curative intent: preliminary results

1 reference

12 December 2020

Hypogonadism in HIV-1-infected men is common and does not resolve during antiretroviral therapy

1 reference

12 December 2020

Testosterone replacement for hypogonadism: clinical findings and best practices

1 reference

12 December 2020

HIV-1 protease inhibitor induces growth arrest and apoptosis of human multiple myeloma cells via inactivation of signal transducer and activator of transcription 3 and extracellular signal-regulated kinase 1/2.

1 reference

12 December 2020

AIDS-defining and non-AIDS-defining malignancies: cancer occurrence in the antiretroviral therapy era.

1 reference

12 December 2020

Plasma viral load testing in the management of HIV infection

1 reference

12 December 2020

Evidence for changes in adrenal and testicular steroids during HIV infection

1 reference

12 December 2020

Non-acquired immunodeficiency syndrome-defining malignancies in patients infected with human immunodeficiency virus

1 reference

12 December 2020

Nonpalpable stage T1c prostate cancer: prediction of insignificant disease using free/total prostate specific antigen levels and needle biopsy findings

1 reference

12 December 2020

Breast cancer before and during the AIDS epidemic in women and men: a study of Tanzanian Cancer Registry Data 1968 to 1996.

1 reference

12 December 2020

Identifiers

DOI

10.1038/NRUROL.2010.61

1 reference

22 August 2017

1 reference